← FDA DRUG APPROVALS

FDA ANDA · ANDA075830

MILRINONE LACTATE

Sponsor: HOSPIRA

APPLICATION
ANDA075830
TYPE
ANDA
ORIGINAL APPROVAL
2002-05-28
LATEST ACTION
2004-08-02
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

MILRINONE LACTATEDiscontinued
MILRINONE LACTATE EQ 1MG BASE/ML · INJECTABLE · INJECTION

Approval history

2004-08-02Labeling · Supplement 2AP
2002-12-20Manufacturing (CMC) · Supplement 1AP
2002-05-28OriginalLabelAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →